Our passion for therapeutic innovation is reflected through our inventions to improve patient responses to drug therapies. Our adjunct therapeutic candidates include the ImmunePrep™ platform to enhance the activity of antibody-based immunotherapies, ChemoPrep™ to improve the delivery of cancer chemotherapies, and ChemoPure™ to reduce the post-treatment toxicity of chemotherapy.